Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Wei, Hui, Zhou, Chunlin, Lin, Dong, Liu, Bingcheng, Li, Yan, Zhao, Xingli, Wei, Shuning, Gong, Benfa, Liu, Kaiqi, Gong, Xiaoyuan, Liu, Yuntao, Zhang, Guangji, Chen, Jiayuan, Zhang, Junping, Jin, Jingjing, Qiu, Shaowei, Gu, Runxia, Wang, Ying, Mi, Yingchang, Wang, Jianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094090/
https://www.ncbi.nlm.nih.gov/pubmed/33054134
http://dx.doi.org/10.3324/haematol.2020.267526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094090/
https://www.ncbi.nlm.nih.gov/pubmed/33054134
http://dx.doi.org/10.3324/haematol.2020.267526

Ejemplares similares